Latest Breaking News On - Medical corporation price - Page 1 : comparemela.com

Journey Medical (DERM) enters into a second licensing agreement with Maruho to develop and commercialize Qbrexza to treat hyperhidrosis in certain Asian countries. The stock surges 18.4%.

Eli lillyZacks investment researchJourney medical corporationDermira incJourney medical corporation priceImage sourceZacks investmentJourney medicalMedical corporation priceMedical corporationZacks rankDynavax technologiesBetter therapeuticsCorcept therapeuticsStrong buyZacks consensus estimate